Axon's Q4 2019 revenue grew by 50% to $172 million, driven by demand for Axon Body 3, TASER 7, and cloud software. Adjusted EBITDA more than tripled to $38 million, representing a 22% margin.
Record quarterly revenue of $172 million, up 50% year over year, included $26 million of Axon Body 3 hardware shipments.
Adjusted EBITDA was a record $38 million, representing 22% margin on revenue.
Annual recurring revenue grew 49% year over year to $161 million.
Total company future contracted revenue grew to $1.23 billion.
For the full year 2020, Axon expects to achieve revenue in the range of $615 million to $625 million and Adjusted EBITDA in the range of $100 million to $105 million.
Visualization of income flow from segment revenue to net income